|
Boster Bio
cyclin a Cyclin A, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cyclin a/product/Boster Bio Average 93 stars, based on 1 article reviews
cyclin a - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Boster Bio
anti cdk6 Anti Cdk6, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti cdk6/product/Boster Bio Average 90 stars, based on 1 article reviews
anti cdk6 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Boster Bio
ccna2 antibody ![]() Ccna2 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ccna2 antibody/product/Boster Bio Average 93 stars, based on 1 article reviews
ccna2 antibody - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Novocastra
anti-cyclin a2 ![]() Anti Cyclin A2, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-cyclin a2/product/Novocastra Average 90 stars, based on 1 article reviews
anti-cyclin a2 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Immunotec inc
human cyclin a2 n-terminal part 11b2g3 antibody ![]() Human Cyclin A2 N Terminal Part 11b2g3 Antibody, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human cyclin a2 n-terminal part 11b2g3 antibody/product/Immunotec inc Average 90 stars, based on 1 article reviews
human cyclin a2 n-terminal part 11b2g3 antibody - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Gentex Corporation
anti-cyclin a2 rabbit polyclonal antibody gst103042 ![]() Anti Cyclin A2 Rabbit Polyclonal Antibody Gst103042, supplied by Gentex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-cyclin a2 rabbit polyclonal antibody gst103042/product/Gentex Corporation Average 90 stars, based on 1 article reviews
anti-cyclin a2 rabbit polyclonal antibody gst103042 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Immunology
Article Title: Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy
doi: 10.3389/fimmu.2024.1426474
Figure Lengend Snippet: CCNA2 identified as the best prognostic gene among monocyte-associated genes. (A, B) Functional analysis of monocyte-related prognostic genes. (C, D) GBM and RandomForest algorithms to screen key prognostic genes in the TCGA-PRAD dataset. (E, F) GBM and RandomForest algorithms to screen key prognostic genes in the GSE16560 dataset. (G, H) KM curves of CCNA2 and ACSM3 in the TCGA-PRAD dataset. (I, J) KM curves of CCNA2 and ACSM3 in the GSE16560 dataset.
Article Snippet: Next,
Techniques: Functional Assay
Journal: Frontiers in Immunology
Article Title: Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy
doi: 10.3389/fimmu.2024.1426474
Figure Lengend Snippet: CCNA2 positively correlates with monocyte infiltration levels. (A) Correlation analysis of CCNA2 and monocyte infiltration levels. (B, C) Analysis of CCNA2 correlation with monocyte markers. (D) Mendelian randomization analysis of high HLA-DR expressing monocytes in relation to prostate cancer. (E–I) Single-cell analysis of the correlation between CCNA2 and immune cell infiltration.
Article Snippet: Next,
Techniques: Expressing, Single-cell Analysis
Journal: Frontiers in Immunology
Article Title: Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy
doi: 10.3389/fimmu.2024.1426474
Figure Lengend Snippet: Functional analysis of CCNA2 in PRAD. (A) KEGG analysis of CCNA2 in PRAD. (B–J) GSEA analysis of CCNA2 in PRAD.
Article Snippet: Next,
Techniques: Functional Assay
Journal: Frontiers in Immunology
Article Title: Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy
doi: 10.3389/fimmu.2024.1426474
Figure Lengend Snippet: CCNA2 has a high binding capacity to PRAD-targeted drugs. (A) Analysis of the binding capacity of CCNA2 to PD1 inhibitors. (B) Analysis of the binding capacity of CCNA2 to bicalutamide. (C) Analysis of the binding capacity of CCNA2 to enzalutamide. (D) Analysis of the binding capacity of CCNA2 to abiraterone.
Article Snippet: Next,
Techniques: Binding Assay
Journal: Frontiers in Immunology
Article Title: Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy
doi: 10.3389/fimmu.2024.1426474
Figure Lengend Snippet: CCNA2 is highly expressed in PRAD and is associated with poor patient prognosis. (A, B) Differential expression of CCNA2 in PRAD. (C) Diagnostic predictive value of CCNA2 in PRAD. (D) KM curve of overall survival of CCNA2 in PRAD. (E) Prognostic predictive value of CCNA2 in PRAD.
Article Snippet: Next,
Techniques: Quantitative Proteomics, Diagnostic Assay